LifeStance to Participate in Upcoming Investor Conferences
SCOTTSDALE, Ariz., May 23, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will participate in the following upcoming investor conferences.
UBS Healthcare Services Cape Cod Summit
Participants: Dave Bourdon, CFO, and Monica Prokocki, VP of Finance and Investor Relations
Date: Tuesday, June 4, 2024
Location: Chatham Bars Inn, Chatham, MA
Note: No presentation due to event format; investor meetings only
Goldman Sachs 45th Annual Healthcare Conference
Presenters: Dave Bourdon, CFO, and Monica Prokocki, VP of Finance and Investor Relations
Date: Monday, June 10, 2024
Location: Loews Miami Beach Hotel, Miami Beach, FL
Time: 10:00 a.m. (Eastern time)
Moderated by: Jamie Perse
If applicable, the presentation will be webcast live, and a replay will be made available following the event, on the Investor Relations section of LifeStance’s website at https://investor.lifestance.com.
About LifeStance Health
Founded in 2017, LifeStance (NASDAQ: LFST) is reimagining mental health. We are one of the nation’s largest providers of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Our mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable and personalized mental health care. LifeStance and its supported practices employ approximately 6,800 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers. To learn more, please visit www.LifeStance.com.
Investor Contact: Monica Prokocki VP of Finance and Investor Relations investor.relations@lifestance.com Media Contact: Brooke Matthews Senior Director of Communications media@lifestance.com
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations